SEC Filings for Alder BioPharmaceuticals Inc. (ALDR)

$ 18.92   0.02 (+0.11%) Volume: 7.36m 4:00 PM EDT Oct 18, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
SC TO-T/A[Amend] Tender offer statement by Third Party610/17/2019
SC 14D9/A[Amend] Solicitation, recommendation statements310/16/2019
SC 14D9/A[Amend] Solicitation, recommendation statements610/11/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals110/10/2019
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals610/10/2019
SC TO-T/A[Amend] Tender offer statement by Third Party25110/10/2019
SC 14D9/A[Amend] Solicitation, recommendation statements410/10/2019
SC TO-T/A[Amend] Tender offer statement by Third Party510/04/2019
SC 14D9/A[Amend] Solicitation, recommendation statements310/04/2019
SC 14D9/A[Amend] Solicitation, recommendation statements310/01/2019
SC TO-T/A[Amend] Tender offer statement by Third Party510/01/2019
SC TO-T/A[Amend] Tender offer statement by Third Party509/27/2019
SC 14D9/A[Amend] Solicitation, recommendation statements309/26/2019
SC 13DGeneral statement of acquisition of beneficial ownership1609/26/2019
3Initial statement of beneficial ownership of securities109/26/2019
<<
First
<
Prev
123456789101112131415